Genetic Testing for Prostate Cancer
Type
Webinaire
DÉTAILS DE L’ACTIVITÉ
Display Date
Wednesday April 26, 2023 // 16:00-17:00 PT ◦ 19:00-20:00 ET ◦ 20:00-21:00 AT
Location
Virtual
Speaker
Michael Kolinsky, Ricardo Rendon, Shamini Selvarajah
CRÉDITS
Accreditation
1 Section 1 Group Learning Credit
Event Description
OBJECTIVE:
- Explain how the results of genetic testing in patients with prostate cancer can influence treatment decisions
- Recognize patients for whom genetic testing should be ordered
- Describe the familial cancer risks of hereditary gene alterations in patients with prostate cancer
- Integrate genetic testing for patients with prostate cancer into their clinical practice
SPEAKERS:
Michael Kolinsky
Cross Cancer Institute and Department of Oncology
University of Alberta
Ricardo Rendon
Department of Urology, Dalhousie University
Queen Elizabeth II Health Sciences Centre
Shamini Selvarajah
Department of Clinical Laboratory Genetics, Laboratory Medicine Program, UHN
Department of Laboratory Medicine and Pathobiology, University of Toronto
Footer
SPONSOR:
